Zobrazeno 1 - 10 of 85 pro vyhledávání: '"Lynch RC"'
1
Malignant Fibrous Histiocytoma
Autor: Mills Nl, Lynch Rc, Setze Tk, Hughes Jp
Publikováno v: Southern Medical Journal. 68:1219-1222
Two patients are presented who had malignant fibrous histiocytomas of the skin and soft tissue. These tumors characteristically consist of a solitary mass, 0.5 cm to 12.0 cm, which has skin fixation, is circumscribed and firm. Microscopically, there
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0eb3c91f6d7d06dbb1c7baa9376dfa
https://doi.org/10.1097/00007611-197510000-00010
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.
Autor: Huang IJ; Department of Pharmacy, UW Medicine, Seattle, WA.; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA., Baek GT; Department of Pharmacy, UW Medicine, Seattle, WA.; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA., Cohen J; Department of Pharmacy, UW Medicine, Seattle, WA.; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA., Khajaviyan S; Department of Research, Fred Hutchinson Cancer Center, Seattle, WA., Louie S; Department of Hematology and Hematologic Malignancies, Fred Hutchinson Cancer Center, Seattle, WA., Samples L; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Smith SD; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Till BG; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Warren EH; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Gopal AK; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Poh C; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Lynch RC; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Ujjani CS; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Shadman M; Division of Hematology and Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Nov 18, pp. OP2400416. Date of Electronic Publication: 2024 Nov 18.
Zobrazit plný text záznamu
7
Akademický článek
Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma.
Autor: Kuczmarski TM; Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA., Lynch RC; Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA.
Publikováno v: British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 100-108. Date of Electronic Publication: 2024 May 02.
Zobrazit plný text záznamu
8
Editorial & Opinion
Toward a cure for cHL without chemotherapy.
Autor: Lynch RC; University of Washington and Fred Hutchinson Cancer Center.
Publikováno v: Blood [Blood] 2024 Feb 29; Vol. 143 (9), pp. 741-742.
Zobrazit plný text záznamu
9
Akademický článek
Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up.
Autor: Ho C; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: carrho@uw.edu., Gopal AK; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Till BG; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Shadman M; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Lynch RC; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Cowan AJ; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Wu QV; Fred Hutchinson Cancer Center, Seattle, WA., Voutsinas J; Fred Hutchinson Cancer Center, Seattle, WA., Rasmussen HA; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA., Blue K; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA., Ujjani CS; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Cassaday RD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA., Fromm JR; Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA., Smith SD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. e33-e39.e1. Date of Electronic Publication: 2023 Oct 18.
Zobrazit plný text záznamu
10
Akademický článek
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
Autor: Trněný M; First Department of Medicine - Hematology, Charles University General Hospital, Prague, Czech Republic., Avigdor A; Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., McKinney MS; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke Cancer Institute, Durham, NC, USA., Paneesha S; Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, Birmingham, UK., Wahlin BE; Karolinska Institutet, Department of Medicine, Huddinge, and Karolinska University Hospital, Unit for Hematology, Stockholm, Sweden., Hrom JS; Forrest General Hospital and Hattiesburg Clinic of Hematology and Oncology, Hattiesburg, MS, USA., Cunningham D; Royal Marsden Hospital, NHS Foundation Trust, London and Surrey, UK., Morley N; Sheffield Teaching Hospital, NHS Foundation Trust, Sheffield and London, UK., Canales M; Hospital Universitario La Paz, Madrid, Spain., Bastos-Oreiro M; Hematology Department, Hospital General Universitario Gregorio Marañón (IiSGM), Madrid, Spain., Belada D; Fourth Department of Internal Medicine - Hematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic., Devizzi L; Division of Hemathology and Stem Cell Transplantation, IRCCS Istituto Nazionale Tumori, Milan, Italy., Zheng F; Incyte Corporation, Wilmington, DE, USA., DeMarini DJ; Incyte Corporation, Wilmington, DE, USA., Jiang W; Incyte Corporation, Wilmington, DE, USA., Jiang P; Incyte Corporation, Wilmington, DE, USA., Lynch RC; University of Washington School of Medicine, Fred Hutch Cancer Center, Seattle, WA, USA.
Publikováno v: EClinicalMedicine [EClinicalMedicine] 2023 Aug 18; Vol. 63, pp. 102130. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje